Megan Maher was awarded a PhD in Inorganic Chemistry from the University of Melbourne. She carried out postdoctoral research at the University of Sydney, Imperial College, London and Centenary Institute in Sydney, which were funded by a series of independent fellowships. Megan relocated to La Trobe University to take up a position as LIMS Senior Research Fellow and progressed to the position of Senior Lecturer and Associate Professor. In 2017 Megan was awarded the Georgina Sweet Award for Women in Quantitative Biomedical Science and in 2018 an ARC Future Fellowship. Megan joined the School of Chemistry and Bio21 at the University of Melbourne in 2019 as part of the University's Driving Research Momentum (DRM) strategy, she was promoted to Professor in 2023 and now holds a joint appointment between the School of Chemistry and the Department of Biochemistry and Pharmacology. Megan is currently the President of the Australian Society of Biochemistry and Molecular Biology and Chair of the Australian Academy of Science National Committee for Crystallography.
Megan is a structural biologist and bioinorganic chemist whose discoveries have revealed fundamental mechanisms of mitochondrial disease, metal homeostasis, membrane protein and metalloprotein structure and function. Her work has advanced how proteins assemble, acquire cofactors, and perform essential biological functions, generating insights across human health, infectious disease, and biotechnology.